According to Dr. Reddy's's latest financial reports the company has $3.21 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-03-31 | $2.81 B | 11.98% |
2022-03-31 | $2.51 B | 6.63% |
2021-03-31 | $2.35 B | 14.63% |
2020-03-31 | $2.05 B | 1.8% |
2019-03-31 | $2.01 B | 3.96% |
2018-03-31 | $1.94 B | 1.45% |
2017-03-31 | $1.91 B | -0.99% |
2016-03-31 | $1.93 B | 8.6% |
2015-03-31 | $1.78 B | 17.34% |
2014-03-31 | $1.51 B | 13.13% |
2013-03-31 | $1.34 B | 18.78% |
2012-03-31 | $1.12 B | 9.54% |
2011-03-31 | $1.03 B | 7.62% |
2010-03-31 | $0.95 B | 15.7% |
2009-03-31 | $0.82 B | -30.25% |
2008-03-31 | $1.18 B | 22.94% |
2007-03-31 | $0.96 B | 92.55% |
2006-03-31 | $0.50 B | 4.37% |
2005-03-31 | $0.48 B | -1.25% |
2004-03-31 | $0.48 B | 116.09% |
2003-03-31 | $0.22 B | 21.61% |
2002-03-31 | $0.18 B | 194.81% |
2001-03-31 | $62.8 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Novartis NVS | $46.75 B | 1,353.01% | ๐จ๐ญ Switzerland |
Pfizer PFE | $89.28 B | 2,675.10% | ๐บ๐ธ USA |
Sanofi SNY | $82.20 B | 2,454.91% | ๐ซ๐ท France |
GlaxoSmithKline GSK | $16.28 B | 406.24% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $8.12 B | 152.56% | ๐ฎ๐ฑ Israel |